Prospective Analysis of Effect of Collagen Wrap Conduit on Radial and Ulnar Nerve Function Following Radial/Ulnar Forearm Free Flap Harvest

Sponsor
The University of Texas Health Science Center, Houston (Other)
Overall Status
Recruiting
CT.gov ID
NCT03875833
Collaborator
(none)
36
1
2
25.7
1.4

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether collagen nerve conduits placed on exposed radial and ulnar nerves during radial and ulnar forearm free flap harvests will reduce the occurrence and degree of sensory nerve deficit.

Condition or Disease Intervention/Treatment Phase
  • Device: Collagen Nerve Wrap Conduit
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
36 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Prospective Analysis of Effect of Collagen Wrap Conduit on Radial and Ulnar Nerve Function Following Radial/Ulnar Forearm Free Flap Harvest
Actual Study Start Date :
Oct 9, 2020
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Collagen Nerve Wrap Conduit

Device: Collagen Nerve Wrap Conduit
The collagen nerve wrap conduit will be placed on all exposed radial and ulnar nerves at the time of free flap harvest.

No Intervention: Control

Outcome Measures

Primary Outcome Measures

  1. Number of participants with normal sensory recovery at the site of forearm free flap as assessed by subjective patient questionnaire regarding upper extremity sensation and function [baseline]

  2. Number of participants with normal sensory recovery at the site of forearm free flap as assessed by subjective patient questionnaire regarding upper extremity sensation and function [3 months]

  3. Number of participants with normal sensory recovery at the site of forearm free flap as assessed by subjective patient questionnaire regarding upper extremity sensation and function [6 months]

  4. Number of participants with normal sensory recovery at the site of forearm free flap as assessed by subjective patient questionnaire regarding upper extremity sensation and function [12 months]

  5. Number of participants with normal sensory recovery at the site of forearm free flap as assessed by objective clinical findings [baseline]

    Participants will be evaluated clinically using pinprick, light touch, and two-point discrimination tests. An overall score will be reported.

  6. Number of participants with normal sensory recovery at the site of forearm free flap as assessed by objective clinical findings [3 months]

    Participants will be evaluated clinically using pinprick, light touch, and two-point discrimination tests. An overall score will be reported.

  7. Number of participants with normal sensory recovery at the site of forearm free flap as assessed by objective clinical findings [6 months]

    Participants will be evaluated clinically using pinprick, light touch, and two-point discrimination tests. An overall score will be reported.

  8. Number of participants with normal sensory recovery at the site of forearm free flap as assessed by objective clinical findings [12 months]

    Participants will be evaluated clinically using pinprick, light touch, and two-point discrimination tests. An overall score will be reported.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients present with a complex defect after tumor resection

  • all these cases done with the departments of Oral and Maxillofacial Surgery and Otolaryngology at the University of Texas in multiple locations that include, Memorial Hermann Hospital, Ben Taub General Hospital, Lyndon B. Johnson General Hospital and The Methodist hospital.

  • patients that have been diagnosed with head and neck tumors and who will undergo a composite resection and reconstruction with radial or ulnar free vascularized flap.

Exclusion Criteria:
  • pre-existing nerve deficits

  • pregnant women

Contacts and Locations

Locations

Site City State Country Postal Code
1 The University of Texas Health Science Center at Houston Houston Texas United States 77030

Sponsors and Collaborators

  • The University of Texas Health Science Center, Houston

Investigators

  • Principal Investigator: James C Melville, DDS, The University of Texas Health Science Center, Houston

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
James C Melville, Assistant Professor, The University of Texas Health Science Center, Houston
ClinicalTrials.gov Identifier:
NCT03875833
Other Study ID Numbers:
  • HSC-DB-18-0760
First Posted:
Mar 15, 2019
Last Update Posted:
Dec 8, 2020
Last Verified:
Dec 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 8, 2020